Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria
Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Rep...
Ausführliche Beschreibung
Autor*in: |
Hyo-Jin Lee [verfasserIn] Dong-Gun Lee [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2022 |
---|
Schlagwörter: |
methicillin-resistant staphylococcus aureus |
---|
Übergeordnetes Werk: |
In: The Korean Journal of Internal Medicine - The Korean Association of Internal Medicine, 2019, 37(2022), 2, Seite 271-280 |
---|---|
Übergeordnetes Werk: |
volume:37 ; year:2022 ; number:2 ; pages:271-280 |
Links: |
Link aufrufen |
---|
DOI / URN: |
10.3904/kjim.2021.527 |
---|
Katalog-ID: |
DOAJ004323076 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ004323076 | ||
003 | DE-627 | ||
005 | 20230309183416.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3904/kjim.2021.527 |2 doi | |
035 | |a (DE-627)DOAJ004323076 | ||
035 | |a (DE-599)DOAJfa02f18f28f74f61a5317e2ab9430feb | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Hyo-Jin Lee |e verfasserin |4 aut | |
245 | 1 | 0 | |a Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date. | ||
650 | 4 | |a anti-bacterial agents | |
650 | 4 | |a drug resistance | |
650 | 4 | |a multiple | |
650 | 4 | |a methicillin-resistant staphylococcus aureus | |
650 | 4 | |a carbapenem-resistant enterobacteriaceae | |
650 | 4 | |a antimicrobial stewardship | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Dong-Gun Lee |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t The Korean Journal of Internal Medicine |d The Korean Association of Internal Medicine, 2019 |g 37(2022), 2, Seite 271-280 |w (DE-627)602537371 |w (DE-600)2500508-X |x 20056648 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2022 |g number:2 |g pages:271-280 |
856 | 4 | 0 | |u https://doi.org/10.3904/kjim.2021.527 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/fa02f18f28f74f61a5317e2ab9430feb |z kostenfrei |
856 | 4 | 0 | |u http://www.kjim.org/upload/pdf/kjim-2021-527.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1226-3303 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2005-6648 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 37 |j 2022 |e 2 |h 271-280 |
author_variant |
h j l hjl d g l dgl |
---|---|
matchkey_str |
article:20056648:2022----::retedonvlniitcirpbiokraoobtutd |
hierarchy_sort_str |
2022 |
publishDate |
2022 |
allfields |
10.3904/kjim.2021.527 doi (DE-627)DOAJ004323076 (DE-599)DOAJfa02f18f28f74f61a5317e2ab9430feb DE-627 ger DE-627 rakwb eng Hyo-Jin Lee verfasserin aut Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date. anti-bacterial agents drug resistance multiple methicillin-resistant staphylococcus aureus carbapenem-resistant enterobacteriaceae antimicrobial stewardship Medicine R Dong-Gun Lee verfasserin aut In The Korean Journal of Internal Medicine The Korean Association of Internal Medicine, 2019 37(2022), 2, Seite 271-280 (DE-627)602537371 (DE-600)2500508-X 20056648 nnns volume:37 year:2022 number:2 pages:271-280 https://doi.org/10.3904/kjim.2021.527 kostenfrei https://doaj.org/article/fa02f18f28f74f61a5317e2ab9430feb kostenfrei http://www.kjim.org/upload/pdf/kjim-2021-527.pdf kostenfrei https://doaj.org/toc/1226-3303 Journal toc kostenfrei https://doaj.org/toc/2005-6648 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 37 2022 2 271-280 |
spelling |
10.3904/kjim.2021.527 doi (DE-627)DOAJ004323076 (DE-599)DOAJfa02f18f28f74f61a5317e2ab9430feb DE-627 ger DE-627 rakwb eng Hyo-Jin Lee verfasserin aut Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date. anti-bacterial agents drug resistance multiple methicillin-resistant staphylococcus aureus carbapenem-resistant enterobacteriaceae antimicrobial stewardship Medicine R Dong-Gun Lee verfasserin aut In The Korean Journal of Internal Medicine The Korean Association of Internal Medicine, 2019 37(2022), 2, Seite 271-280 (DE-627)602537371 (DE-600)2500508-X 20056648 nnns volume:37 year:2022 number:2 pages:271-280 https://doi.org/10.3904/kjim.2021.527 kostenfrei https://doaj.org/article/fa02f18f28f74f61a5317e2ab9430feb kostenfrei http://www.kjim.org/upload/pdf/kjim-2021-527.pdf kostenfrei https://doaj.org/toc/1226-3303 Journal toc kostenfrei https://doaj.org/toc/2005-6648 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 37 2022 2 271-280 |
allfields_unstemmed |
10.3904/kjim.2021.527 doi (DE-627)DOAJ004323076 (DE-599)DOAJfa02f18f28f74f61a5317e2ab9430feb DE-627 ger DE-627 rakwb eng Hyo-Jin Lee verfasserin aut Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date. anti-bacterial agents drug resistance multiple methicillin-resistant staphylococcus aureus carbapenem-resistant enterobacteriaceae antimicrobial stewardship Medicine R Dong-Gun Lee verfasserin aut In The Korean Journal of Internal Medicine The Korean Association of Internal Medicine, 2019 37(2022), 2, Seite 271-280 (DE-627)602537371 (DE-600)2500508-X 20056648 nnns volume:37 year:2022 number:2 pages:271-280 https://doi.org/10.3904/kjim.2021.527 kostenfrei https://doaj.org/article/fa02f18f28f74f61a5317e2ab9430feb kostenfrei http://www.kjim.org/upload/pdf/kjim-2021-527.pdf kostenfrei https://doaj.org/toc/1226-3303 Journal toc kostenfrei https://doaj.org/toc/2005-6648 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 37 2022 2 271-280 |
allfieldsGer |
10.3904/kjim.2021.527 doi (DE-627)DOAJ004323076 (DE-599)DOAJfa02f18f28f74f61a5317e2ab9430feb DE-627 ger DE-627 rakwb eng Hyo-Jin Lee verfasserin aut Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date. anti-bacterial agents drug resistance multiple methicillin-resistant staphylococcus aureus carbapenem-resistant enterobacteriaceae antimicrobial stewardship Medicine R Dong-Gun Lee verfasserin aut In The Korean Journal of Internal Medicine The Korean Association of Internal Medicine, 2019 37(2022), 2, Seite 271-280 (DE-627)602537371 (DE-600)2500508-X 20056648 nnns volume:37 year:2022 number:2 pages:271-280 https://doi.org/10.3904/kjim.2021.527 kostenfrei https://doaj.org/article/fa02f18f28f74f61a5317e2ab9430feb kostenfrei http://www.kjim.org/upload/pdf/kjim-2021-527.pdf kostenfrei https://doaj.org/toc/1226-3303 Journal toc kostenfrei https://doaj.org/toc/2005-6648 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 37 2022 2 271-280 |
allfieldsSound |
10.3904/kjim.2021.527 doi (DE-627)DOAJ004323076 (DE-599)DOAJfa02f18f28f74f61a5317e2ab9430feb DE-627 ger DE-627 rakwb eng Hyo-Jin Lee verfasserin aut Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date. anti-bacterial agents drug resistance multiple methicillin-resistant staphylococcus aureus carbapenem-resistant enterobacteriaceae antimicrobial stewardship Medicine R Dong-Gun Lee verfasserin aut In The Korean Journal of Internal Medicine The Korean Association of Internal Medicine, 2019 37(2022), 2, Seite 271-280 (DE-627)602537371 (DE-600)2500508-X 20056648 nnns volume:37 year:2022 number:2 pages:271-280 https://doi.org/10.3904/kjim.2021.527 kostenfrei https://doaj.org/article/fa02f18f28f74f61a5317e2ab9430feb kostenfrei http://www.kjim.org/upload/pdf/kjim-2021-527.pdf kostenfrei https://doaj.org/toc/1226-3303 Journal toc kostenfrei https://doaj.org/toc/2005-6648 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 37 2022 2 271-280 |
language |
English |
source |
In The Korean Journal of Internal Medicine 37(2022), 2, Seite 271-280 volume:37 year:2022 number:2 pages:271-280 |
sourceStr |
In The Korean Journal of Internal Medicine 37(2022), 2, Seite 271-280 volume:37 year:2022 number:2 pages:271-280 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
anti-bacterial agents drug resistance multiple methicillin-resistant staphylococcus aureus carbapenem-resistant enterobacteriaceae antimicrobial stewardship Medicine R |
isfreeaccess_bool |
true |
container_title |
The Korean Journal of Internal Medicine |
authorswithroles_txt_mv |
Hyo-Jin Lee @@aut@@ Dong-Gun Lee @@aut@@ |
publishDateDaySort_date |
2022-01-01T00:00:00Z |
hierarchy_top_id |
602537371 |
id |
DOAJ004323076 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ004323076</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309183416.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3904/kjim.2021.527</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ004323076</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJfa02f18f28f74f61a5317e2ab9430feb</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Hyo-Jin Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anti-bacterial agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">drug resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">multiple</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">methicillin-resistant staphylococcus aureus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">carbapenem-resistant enterobacteriaceae</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antimicrobial stewardship</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dong-Gun Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">The Korean Journal of Internal Medicine</subfield><subfield code="d">The Korean Association of Internal Medicine, 2019</subfield><subfield code="g">37(2022), 2, Seite 271-280</subfield><subfield code="w">(DE-627)602537371</subfield><subfield code="w">(DE-600)2500508-X</subfield><subfield code="x">20056648</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:271-280</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3904/kjim.2021.527</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/fa02f18f28f74f61a5317e2ab9430feb</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.kjim.org/upload/pdf/kjim-2021-527.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1226-3303</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2005-6648</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2022</subfield><subfield code="e">2</subfield><subfield code="h">271-280</subfield></datafield></record></collection>
|
author |
Hyo-Jin Lee |
spellingShingle |
Hyo-Jin Lee misc anti-bacterial agents misc drug resistance misc multiple misc methicillin-resistant staphylococcus aureus misc carbapenem-resistant enterobacteriaceae misc antimicrobial stewardship misc Medicine misc R Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria |
authorStr |
Hyo-Jin Lee |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)602537371 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut |
collection |
DOAJ |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
20056648 |
topic_title |
Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria anti-bacterial agents drug resistance multiple methicillin-resistant staphylococcus aureus carbapenem-resistant enterobacteriaceae antimicrobial stewardship |
topic |
misc anti-bacterial agents misc drug resistance misc multiple misc methicillin-resistant staphylococcus aureus misc carbapenem-resistant enterobacteriaceae misc antimicrobial stewardship misc Medicine misc R |
topic_unstemmed |
misc anti-bacterial agents misc drug resistance misc multiple misc methicillin-resistant staphylococcus aureus misc carbapenem-resistant enterobacteriaceae misc antimicrobial stewardship misc Medicine misc R |
topic_browse |
misc anti-bacterial agents misc drug resistance misc multiple misc methicillin-resistant staphylococcus aureus misc carbapenem-resistant enterobacteriaceae misc antimicrobial stewardship misc Medicine misc R |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
The Korean Journal of Internal Medicine |
hierarchy_parent_id |
602537371 |
hierarchy_top_title |
The Korean Journal of Internal Medicine |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)602537371 (DE-600)2500508-X |
title |
Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria |
ctrlnum |
(DE-627)DOAJ004323076 (DE-599)DOAJfa02f18f28f74f61a5317e2ab9430feb |
title_full |
Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria |
author_sort |
Hyo-Jin Lee |
journal |
The Korean Journal of Internal Medicine |
journalStr |
The Korean Journal of Internal Medicine |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2022 |
contenttype_str_mv |
txt |
container_start_page |
271 |
author_browse |
Hyo-Jin Lee Dong-Gun Lee |
container_volume |
37 |
format_se |
Elektronische Aufsätze |
author-letter |
Hyo-Jin Lee |
doi_str_mv |
10.3904/kjim.2021.527 |
author2-role |
verfasserin |
title_sort |
urgent need for novel antibiotics in republic of korea to combat multidrug-resistant bacteria |
title_auth |
Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria |
abstract |
Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date. |
abstractGer |
Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date. |
abstract_unstemmed |
Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
2 |
title_short |
Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria |
url |
https://doi.org/10.3904/kjim.2021.527 https://doaj.org/article/fa02f18f28f74f61a5317e2ab9430feb http://www.kjim.org/upload/pdf/kjim-2021-527.pdf https://doaj.org/toc/1226-3303 https://doaj.org/toc/2005-6648 |
remote_bool |
true |
author2 |
Dong-Gun Lee |
author2Str |
Dong-Gun Lee |
ppnlink |
602537371 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3904/kjim.2021.527 |
up_date |
2024-07-03T23:10:33.578Z |
_version_ |
1803601296573333504 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ004323076</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309183416.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3904/kjim.2021.527</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ004323076</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJfa02f18f28f74f61a5317e2ab9430feb</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Hyo-Jin Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Multidrug resistance in bacteria is an important issue and is increasing in frequency worldwide because of the limitations of therapeutic agents. From 2010 to 2019, 14 new systemic antibiotics received regulatory approval in the United States. However, few new antibiotics have been introduced in Republic of Korea to combat multidrug-resistant pathogens. Here, we introduce six novel antibiotics for Gram-positive bacteria and five for Gram-negative bacteria approved by the United States Food and Drug Administration and the European Medicines Agency from 2009 to October 2021, and recommend that they be approved for use in Republic of Korea at the earliest possible date.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">anti-bacterial agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">drug resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">multiple</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">methicillin-resistant staphylococcus aureus</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">carbapenem-resistant enterobacteriaceae</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">antimicrobial stewardship</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">R</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dong-Gun Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">The Korean Journal of Internal Medicine</subfield><subfield code="d">The Korean Association of Internal Medicine, 2019</subfield><subfield code="g">37(2022), 2, Seite 271-280</subfield><subfield code="w">(DE-627)602537371</subfield><subfield code="w">(DE-600)2500508-X</subfield><subfield code="x">20056648</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:271-280</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3904/kjim.2021.527</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/fa02f18f28f74f61a5317e2ab9430feb</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.kjim.org/upload/pdf/kjim-2021-527.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1226-3303</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2005-6648</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2022</subfield><subfield code="e">2</subfield><subfield code="h">271-280</subfield></datafield></record></collection>
|
score |
7.3996534 |